Common GLP-1 medications include: Semaglutide: Sold as Ozempic for diabetes treatment and Wegovy for weight management Tirzepatide: Sold as Mounjaro for diabetes and Zepbound for weight management Liraglutide: Sold as Victoza for diabetes and Saxenda for weight management Dulaglutide: Sold as Trulicity for diabetes treatment These medications are typically administered as once-weekly injections, though some, like the Wegovy pill, are available in oral form as once-daily pills
Not a long-term protocol
Quick Answer: Accidental intravenous injection of Ozempic is extremely unlikely with correct technique but would cause immediate bloodstream entry rather than gradual absorption, potentially increasing adverse effect risk
People were matched on factors including age, sex, race, BMI, and diabetes status to create comparable groups of GLP-1 users and nonusers
This approach ensures safety, potency, and quality control, all validated by extensive FDA oversight and clinical studies